See also this year's filing and all EDGAR filings for this company.
PDF Report 0001662524_2018_Akcea_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001662524, Akcea Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 266,845,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,221,000 |
| 2 | PropertyPlantAndEquipmentNet | 77,000 |
| 3 | remainder_Assets | 661,000 |
| 4 | LiabilitiesCurrent | 80,853,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 8,318,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,981,000 |
| 9 | ResearchAndDevelopmentExpense | 126,890,000 |
| 10 | remainder_Expenses | 3,006,000 |
| 11 | remainder_Revenues | 55,313,000 |
| 12 | remainder_NetIncome | 1,813,000 |
| 13 | remainder_ComprehensiveNetIncome | -430,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 268,804,000 |
| 1 | Liabilities | 89,171,000 |
| 2 | Expenses | 166,877,000 |
| 3 | Revenues | 55,313,000 |
| 4 | StockholdersEquity | 179,633,000 |
| 5 | NetIncome | -109,751,000 |
| 6 | ComprehensiveNetIncome | -109,966,000 |
| 7 | BaseVar | 291,204,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.57 |
| 9 | EconomicCapitalRatio | 2.73 |
Edgar->Model Mapping
Feature Distribution
